The Context: Studying brain development can be difficult since scientists cannot easily access developing brain tissue. Creating models of human brain development from stem cells allows...
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
The Context: NRXN1 is a gene that is broadly implicated in neuropsychiatric disorders such as schizophrenia, autism spectrum disorder, and epilepsy; however, the ways in which...
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
The Context: Schizophrenia has a strong genetic component. Scientists have discovered many genetic variants that may play a role in its onset, but each individual variant...
The Context: To fit inside the nucleus of our cells, our DNA crumples up, forming loops and making itself compact. When certain sequences of looped DNA...
The Context: CRISPR is a powerful gene editing tool which traditionally works by locating and modifying stretches of DNA within the genome. However, this technique creates...
The Context: CRISPR is a powerful, ‘word-processor’-like tool for editing DNA, but currently it is much easier to eliminate undesired sequences than it is to accurately...
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
“After 3.8 billion years of evolving by Darwinian principles, we are turning a corner and taking more control over all biology, including our own,” explained Jamie...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
Reports this week that a researcher in China has created genetically modified children using the gene editing technology CRISPR have been met with widespread concern. Dr....
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
The sequence of bases (As, Cs, Gs, and Ts) that make up our DNA matters: it is what determines our genetic blueprint, which in turn determines...
In a new study published in Neuron, a team from Boston Children’s Hospital led by NYSCF – Robertson Neuroscience Investigator Maria Lehtinen, PhD, discovered that a...
In a new article from the patient advocacy and research nonprofit Jordan’s Guardian Angels, NYSCF speaks about its work creating induced pluripotent stem cells from patients with Jordan’s...
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
NYSCF – Robertson Investigator Feng Zhang, PhD, Core Member at the Broad Institute of MIT and Harvard and Professor of Brain and Cognitive Sciences and Biological Engineering at...
Researchers at the California Institute of Technology led by NYSCF – Robertson Investigator Mitchell Guttman, PhD, have developed a new tool called SPRITE to uncover how...
This week, NYSCF – Robertson Investigators Feng Zhang, PhD (MIT), Ed Boyden, PhD (MIT), Gaby Maimon, PhD (The Rockefeller University), and Zachary Knight, PhD (University of...
NYSCF – Robertson Investigator Feng Zhang, PhD, Core Member at Broad Institute of MIT and Harvard, Professor at Massachusetts Institute of Technology, along with David Liu, PhD, Professor...
NYSCF – Robertson Stem Cell Investigator Alexander Meissner, PhD, of the Max Planck Institute for Molecular Genetics was one of 62 scientists recently inducted into the...
NYSCF — Robertson Investigator and MIT professor Feng Zhang, PhD, was interviewed on CBS’s 60 Minutes about CRISPR, the gene editing technology he helped pioneer that...
